Infection Surveillance Solutions Market To Reach $1.48 Billion By 2030

Infection Surveillance Solutions Market Growth & Trends

The global infection surveillance solutions market size is expected to reach USD 1.48 billion by 2030, registering a CAGR of 13.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare-associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in the European Union (EU) from antibiotic-resistant bacteria. The figure is expected to increase to 10 million deaths per year if the current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, the Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed a partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up the AMR surveillance network in India.

 Request a free sample copy or view report summary: Infection Surveillance Solutions Market Report

Infection Surveillance Solutions Market Report Highlights

• The software segment dominated with a market share of 63.4% in 2023. The use of web-based software provides real-time analysis and different configurations.

• The services segment is expected to be the fastest-growing segment with a CAGR of 13.5% during the forecast period.

• The hospital segment dominated with a market share of 79.3% in 2023. High purchasing power by healthcare institutes, the growing need for tracking software, and the presence of skilled medical professionals are poised to contribute to the segment's growth.

• Long-term care facilities are expected to be the fastest-growing segment with a CAGR of 14.0% during the forecast period.

• North America infection surveillance solutions market accounted for a global share of 50.3% in 2023.

• Europe's infection surveillance solutions market is fast-growing with a global share of 22.2% in 2023. The growth can be attributed to factors such as an increase in medical tourism, a rise in chronic diseases, and an outbreak of COVID-19 majorly played a role in influencing the market growth.

Infection Surveillance Solutions Market Segmentation

Grand View Research has segmented global infection surveillance solutions market report based on component, end-use, and region:

Infection Surveillance Solutions Component Outlook (Revenue, USD Million, 2018 - 2030)

• Software

• Services

Infection Surveillance Solutions End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Long Term Care Facilities

• Others

Infection Surveillance Solutions Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Spain

  • Italy

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • Kuwait

  • South Africa

List of Key Players of Infection Surveillance Solutions Market

• Becton Dickinson and Company

• Premier, Inc.

• Wolters Kluwer N.V.

• Baxter International Inc.

• Cerner Corporation (Oracle)

• Clinisys

• GOJO Industries

• Merative

• Truven Health Analytics

• Vigilanz Corporation

• RL Datix Ltd